A carregar...
Publicação
The impact of covid-19 on valuation differences in public and private healthcare companies
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 473.76 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Valuation discounts of privately-owned companies compared to publicly-listed ones are
prevalent in many industries and are a commonly accepted concept. This paper studies valuation
differences between public and private companies in the healthcare sector. Further, it examines
whether such differences were impacted by the outbreak of the Covid-19 pandemic. In the
sample studied herein, private companies are valued at a premium, but that difference is not
statistically significant. In addition, the impact Covid-19 had on the valuation differences
between public and private companies in the healthcare sector so far cannot be generalized
according to the traits studied herein.
Descrição
Palavras-chave
Valuation Public market Private market Private company discount Covid-19 Healthcare